NEW YORK (GenomeWeb News) – Exiqon has granted Applied Biosystems a license to use its locked nucleic acids intellectual property in siRNA projects, the Danish company said today.

 

Exiqon said the agreement fulfills one of its strategic goals for 2008, which was to license its LNA technology to a “major tool provider.” The company said the IP “offers many more possibilities for developing competitive products” than it has the means to pursue.

 

Financial terms of the agreement were not released.